Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 58.92% vs -7.53% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is -100.00% vs 75.00% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 9.09% vs 71.43% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 1,162.79% vs 0.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 8.12% vs 40.20% in Mar 2025
Compare Balance Sheet Results of Vaishali Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
26.09
10.25
15.84
154.54%
Share Warrants & Outstandings
Total Reserve
42.89
130.22
-87.33
-67.06%
Shareholder's Funds
68.99
140.47
-71.48
-50.89%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
6.22
0.00
6.22
0.00%
Secured Loans
6.22
0.00
6.22
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.15
1.01
-1.16
-114.85%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.29
0.00
0.29
0.00%
Total Non-Current Liabilities
5.82
1.01
4.81
476.24%
Current Liabilities
Trade Payables
21.18
2.50
18.68
747.20%
Other Current Liabilities
14.03
4.05
9.98
246.42%
Short Term Borrowings
12.84
0.00
12.84
0.00%
Short Term Provisions
0.25
0.00
0.25
0.00%
Total Current Liabilities
48.30
6.56
41.74
636.28%
Total Liabilities
123.11
148.04
-24.93
-16.84%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.93
49.45
-45.52
-92.05%
Less: Accumulated Depreciation
2.49
30.57
-28.08
-91.85%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.44
18.88
-17.44
-92.37%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.25
0.00
0.25
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
5.43
0.00
5.43
0.00%
Long Term Loans & Advances
1.14
1.12
0.02
1.79%
Other Non Current Assets
1.63
20.09
-18.46
-91.89%
Total Non-Current Assets
10.14
40.10
-29.96
-74.71%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.40
9.92
-6.52
-65.73%
Sundry Debtors
50.77
19.54
31.23
159.83%
Cash and Bank
1.43
75.32
-73.89
-98.10%
Other Current Assets
1.05
2.55
-1.50
-58.82%
Short Term Loans and Advances
56.31
0.62
55.69
8,982.26%
Total Current Assets
112.96
107.95
5.01
4.64%
Net Current Assets (Including Current Investments)
64.66
101.39
-36.73
-36.23%
Total Current Assets Excluding Current Investments
112.96
107.95
5.01
4.64%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
123.11
148.04
-24.93
-16.84%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
18.00
0.00
18.00
0.00%
Book Value per share (adjusted)
0.00
137.11
-137.11
-100.00%
Annual - Borrowings
Borrowings 18.53 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 58.92% vs -7.53% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs 75.00% in Mar 2025
Annual - Fixed Assets
Fixed Assets 1.44 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.09% vs 71.43% in Mar 2025
Annual - Investments
Investments 5.43 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1,162.79% vs 0.00% in Mar 2025
Annual - Current Assets
Current Assets 112.96 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.12% vs 40.20% in Mar 2025
Footer loading
